Injectable ion-coordinated double-network conductive hydrogel for spinal cord injury repair.

IF 4.8 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-06-09 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1618680
Huan Yu, Fan Liu, Yaorui Hu, Weikang Wan, Qing Liu, Shuai Zhou, Luping Zhang, Liming Li, Fei Huang
{"title":"Injectable ion-coordinated double-network conductive hydrogel for spinal cord injury repair.","authors":"Huan Yu, Fan Liu, Yaorui Hu, Weikang Wan, Qing Liu, Shuai Zhou, Luping Zhang, Liming Li, Fei Huang","doi":"10.3389/fbioe.2025.1618680","DOIUrl":null,"url":null,"abstract":"<p><p>The mammalian central nervous system (CNS) demonstrates a severely limited capacity for spontaneous neural regeneration after traumatic spinal cord injury (SCI). Structural repair is also highly constrained due to the inhibitory microenvironment. This inherent limitation persists throughout the recovery phase and often leads to severe motor and sensory dysfunction, profoundly impairing patients' quality of life. Current clinical treatments, including surgical decompression, pharmacological interventions, and rehabilitation therapy, can only partially relieve symptoms. They are not enough to promote neural regeneration and functional recovery. There is an urgent need to develop novel therapeutic approaches to overcome this challenge. This study developed and created an injectable double-network conductive hydrogel, it coordinates iron ions (Fe<sup>3+</sup>) using dynamic Schiff base bonds and metal ion coordination. The conductive hydrogel aids in spinal cord injury repair through various mechanisms, such as reducing glial scar formation, promoting remyelination, and providing neuroprotection. This makes it an injection therapy with promising prospects for clinical translation in the field of nerve regeneration.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1618680"},"PeriodicalIF":4.8000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183279/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1618680","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The mammalian central nervous system (CNS) demonstrates a severely limited capacity for spontaneous neural regeneration after traumatic spinal cord injury (SCI). Structural repair is also highly constrained due to the inhibitory microenvironment. This inherent limitation persists throughout the recovery phase and often leads to severe motor and sensory dysfunction, profoundly impairing patients' quality of life. Current clinical treatments, including surgical decompression, pharmacological interventions, and rehabilitation therapy, can only partially relieve symptoms. They are not enough to promote neural regeneration and functional recovery. There is an urgent need to develop novel therapeutic approaches to overcome this challenge. This study developed and created an injectable double-network conductive hydrogel, it coordinates iron ions (Fe3+) using dynamic Schiff base bonds and metal ion coordination. The conductive hydrogel aids in spinal cord injury repair through various mechanisms, such as reducing glial scar formation, promoting remyelination, and providing neuroprotection. This makes it an injection therapy with promising prospects for clinical translation in the field of nerve regeneration.

可注射协调双网络导电水凝胶用于脊髓损伤修复。
哺乳动物中枢神经系统(CNS)在创伤性脊髓损伤(SCI)后显示出严重有限的自发神经再生能力。由于抑制微环境,结构修复也受到高度限制。这种固有的限制在整个恢复阶段持续存在,并经常导致严重的运动和感觉功能障碍,严重损害患者的生活质量。目前的临床治疗,包括手术减压、药物干预和康复治疗,只能部分缓解症状。它们不足以促进神经再生和功能恢复。迫切需要开发新的治疗方法来克服这一挑战。本研究开发并制备了一种可注射的双网络导电水凝胶,它利用动态希夫碱键和金属离子配位来配位铁离子(Fe3+)。导电水凝胶通过减少神经胶质瘢痕形成、促进髓鞘再生、提供神经保护等多种机制促进脊髓损伤修复。这使其成为一种在神经再生领域具有临床应用前景的注射疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信